These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34185586)

  • 41. Management and Visual Outcomes of Acute Bacterial Endophthalmitis Following Intravitreal Injection of Contaminated Bevacizumab in a Single Day.
    Xu K; Mousa R; Loewenstein A; Barak A; Chin EK; Almeida DRP
    Ophthalmic Surg Lasers Imaging Retina; 2020 Jun; 51(6):346-352. PubMed ID: 32579693
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of Acute Endophthalmitis With Intravitreal Injections of Corticosteroids or Anti-Vascular Growth Factor Agents in a Nationwide Study in France.
    Baudin F; Benzenine E; Mariet AS; Bron AM; Daien V; Korobelnik JF; Quantin C; Creuzot-Garcher C
    JAMA Ophthalmol; 2018 Dec; 136(12):1352-1358. PubMed ID: 30242325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab.
    Storey PP; Tauqeer Z; Yonekawa Y; Todorich B; Wolfe JD; Shah SP; Shah AR; Koto T; Abbey AM; Morizane Y; Sharma P; Wood EH; Morizane-Hosokawa M; Pendri P; Pancholy M; Harkey S; Jeng-Miller KW; Obeid A; Borkar DS; Chen E; Williams P; Okada AA; Inoue M; Shiraga F; Hirakata A; Shah CP; Prenner J; Garg S;
    Am J Ophthalmol; 2019 Mar; 199():200-208. PubMed ID: 30552891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis.
    Souied EH; Dugel PU; Ferreira A; Hashmonay R; Lu J; Kelly SP
    Ophthalmic Epidemiol; 2016; 23(2):71-9. PubMed ID: 26855278
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An outbreak of streptococcus endophthalmitis after intravitreal injection of bevacizumab.
    Goldberg RA; Flynn HW; Isom RF; Miller D; Gonzalez S
    Am J Ophthalmol; 2012 Feb; 153(2):204-208.e1. PubMed ID: 22264943
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence of endophthalmitis after intravitreal injections at a tertiary care hospital.
    Zafar S; Hamid A; Bin Mahmood SU; Burq MA; Maqsood N
    Can J Ophthalmol; 2018 Apr; 53(2):94-97. PubMed ID: 29631833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravitreal bevacizumab: safety of multiple doses from a single vial for consecutive patients.
    Ng DS; Kwok AK; Chan CW; Li WW
    Hong Kong Med J; 2012 Dec; 18(6):488-95. PubMed ID: 23223649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of prophylactic topical antibiotics on bacterial resistance patterns in endophthalmitis following intravitreal injection.
    Storey P; Dollin M; Rayess N; Pitcher J; Reddy S; Vander J; Hsu J; Garg S;
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):235-42. PubMed ID: 25940556
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence of endophthalmitis after intravitreal injection with and without topical antibiotic prophylaxis.
    Torres-Costa S; Ramos D; Brandão E; Carneiro Â; Rosas V; Rocha-Sousa A; Falcão-Reis F; Falcão M
    Eur J Ophthalmol; 2021 Mar; 31(2):600-606. PubMed ID: 32019339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence of endophthalmitis after intravitreal injection of antivascular endothelial growth factor medications using topical lidocaine gel anesthesia.
    Inman ZD; Anderson NG
    Retina; 2011 Apr; 31(4):669-72. PubMed ID: 21178659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endophthalmitis after resident-performed intravitreal bevacizumab injection.
    Falavarjani KG; Aghamirsalim M; Modarres M; Hadavandkhani A; Hashemi M; Parvaresh MM; Naseripour M; Samiy N
    Can J Ophthalmol; 2015 Feb; 50(1):33-6. PubMed ID: 25677280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Endophthalmitis following same-day bilateral anti-VEGF injections: a systematic review.
    Bjerager J; Hajari J; Klefter ON; Subhi Y; Schneider M
    Int Ophthalmol; 2024 Feb; 44(1):37. PubMed ID: 38332399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative Study of Microbiological Profile and Management Outcomes of Acute Endophthalmitis after Microincision Vitrectomy Surgery versus Intravitreal Injections.
    Kannan NB; Sen S; Mishra C; Lalitha P; Rameshkumar G; Rajan RP; Arumugam KK; Ramasamy K
    Ocul Immunol Inflamm; 2021 Jul; 29(5):838-844. PubMed ID: 31900009
    [No Abstract]   [Full Text] [Related]  

  • 54. Infectious and noninfectious endophthalmitis after intravitreal bevacizumab.
    Jonas JB; Spandau UH; Rensch F; Von Baltz S; Schlichtenbrede F
    J Ocul Pharmacol Ther; 2007 Jun; 23(3):240-2. PubMed ID: 17593007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting.
    Pilli S; Kotsolis A; Spaide RF; Slakter J; Freund KB; Sorenson J; Klancnik J; Cooney M
    Am J Ophthalmol; 2008 May; 145(5):879-82. PubMed ID: 18329624
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute Endophthalmitis after Intravitreal Bevacizumab Injections at The Tertiary Centre in Nepal.
    Pradhan E; Duwal S; Bajimaya S; Thapa R; Sharma S; Manandhar A
    Nepal J Ophthalmol; 2018 Jan; 10(19):107-110. PubMed ID: 31056587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTIONS DURING THE COVID-19 PANDEMIC WITH IMPLEMENTATION OF UNIVERSAL MASKING.
    Naguib MM; Ghauri S; Mukhopadhyay A; Schefler AC
    Retina; 2021 Nov; 41(11):2208-2214. PubMed ID: 33958531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ocular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degeneration.
    Day S; Acquah K; Mruthyunjaya P; Grossman DS; Lee PP; Sloan FA
    Am J Ophthalmol; 2011 Aug; 152(2):266-72. PubMed ID: 21664593
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Posterior vitreous attachment as a risk factor for endophthalmitis following intravitreal antivascular endothelial growth factor injection.
    Karahan E; Acan D; Toprak MK
    Int Ophthalmol; 2024 May; 44(1):225. PubMed ID: 38748185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NO EFFECT OF REAL-WORLD UNIVERSAL FACE MASKING ON POST-INTRAVITREAL INJECTION ENDOPHTHALMITIS RATE AT A SINGLE TERTIARY ACADEMIC CENTER.
    Haliyur R; Sinha AK; Andrews CA; Musch DC; Conrady CD; Zacks DN; Huvard MJ
    Retina; 2024 May; 44(5):916-922. PubMed ID: 38207176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.